| Trial ID: | L6000 |
| Source ID: | NCT01497132
|
| Associated Drug: |
Vitamin D3
|
| Title: |
Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2
|
| Acronym: |
EVIDENS
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Glucose Intolerance|Vitamin D Deficiency
|
| Interventions: |
DRUG: Vitamin D3|DRUG: Placebo
|
| Outcome Measures: |
Primary: Beta cell function, Assessed by hyperglycemic clamp investigation, 8 weeks | Secondary: Insulin sensitivity, Assessed by hyperglycemic clamp investigation, 8 weeks|Glucose tolerance, Assessed by OGTT, 8 weeks|Hypercalcemia, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: Karolinska Institutet
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
44
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2013-05
|
| Results First Posted: |
|
| Last Update Posted: |
2014-09-10
|
| Locations: |
Dpt of Endocrinology, Karolinska University Hospital, Stockholm, 17176, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01497132
|
